Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Mitratech announces the launch of its Global GRC Platform, unifying risk data with ARIES™ AI to deliver connected, boardroom-ready intelligence.
-
BD² Releases Largest Multi‑Modal Psychiatric Dataset to Accelerate Breakthroughs in Bipolar Disorder
Washington, D.C., March 30, 2026 (GLOBE NEWSWIRE) -- Highlights: Historic Scale: Data from 615 participants across initial six sites, forming the most comprehensive multimodal dataset ever...
-
TORONTO, March 30, 2026 (GLOBE NEWSWIRE) -- With hockey season reaching full tilt, cheers for Winnipeg Jets left wing Kyle Connor are about to get even louder and a little more delicious. KFC Canada...
-
NETANYA, Israel, March 30, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board. Dr. Levi will...
-
Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the...
-
Wheels wins two 2026 AI Excellence Awards for its ML program and AI policy platform, highlighting client‑focused innovation in fleet management.
-
LOS ANGELES, March 30, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Corcept Therapeutics Incorporated, (“Corcept” or the "Company") (NASDAQ: CORT) investors of a class action on behalf of...
-
VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) -- Reinventy Solutions Corp. is presenting SES-34 (SHARKΩ — Proto-SES-34), an advanced unmanned low-observable maritime platform...
-
Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data In vitro analysis of the SeaStar Medical SCD...
-
Trial advancing with ongoing safety and pharmacologic evaluation and planned expansion into MDS and MF SOUTH SAN FRANCISCO, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings,...